CHRISTOPHER AYEKO: Open Payments
NPI 1174911994 · UKIAH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 10 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $141 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $159 |
| Abbott Laboratories | 2 | $136 |
| Novo Nordisk Inc | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $98 |
Products named: FREESTYLE LIBRE 3, Ozempic, ZEPBOUND, Epclusa, MOUNJARO.
Industry payments across CA — which companies pay providers there.
